AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 20,391 | 24,762 | 22,098 | 20,515 | 19,069 |
| Operating Income | -20,391 | -24,762 | -22,098 | -20,515 | -19,069 |
| Interest Expense | 167 | 188 | 197 | 222 | 29 |
| Other Income | 152 | 1,861 | 4,953 | -195 | 600 |
| Pre-tax Income | -20,406 | -23,089 | -17,343 | -20,932 | -18,498 |
| Income Tax | 4 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -20,411 | -23,093 | -17,343 | -20,932 | -18,498 |
| Net Income | $-20,411 | $-23,093 | $-17,343 | $-20,932 | $-18,498 |
| EPS Basic Total Ops | -0.25 | -0.28 | -0.24 | -0.29 | -0.25 |
| EPS Basic Continuous Ops | -0.24 | -0.28 | -0.24 | -0.29 | -0.26 |
| EPS Diluted Total Ops | -0.25 | -0.28 | -0.24 | -0.29 | -0.25 |
| EPS Diluted Continuous Ops | -0.24 | -0.28 | -0.24 | -0.29 | -0.26 |
| EBITDA(a) | $-19,741 | $-24,067 | $-21,414 | $-19,868 | $-18,464 |